Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol dose-finding for pediatric upper gastrointestinal endoscopy sedation
ChiCTR2300074880Phase 4Not yet recruiting
- Sponsor
- Qingdao Women and Children’s Hospital
- Start
- Aug 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None (2 arms), sponsored by Qingdao Women and Children’s Hospital. Primary endpoint: 50% Effective Dose of Ciprofol (ED50). Planned start Aug 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300074880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074880.